Solèr M - Search Results

1

Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma.

Buhl R, Solèr M, Matz J, Townley R, O'Brien J, Noga O, Champain K, Fox H, Thirlwell J, Della Cioppa G. Buhl R, et al. Among authors: soler m. Eur Respir J. 2002 Jul;20(1):73-8. doi: 10.1183/09031936.02.00278102. Eur Respir J. 2002. PMID: 12166585 Free article. Clinical Trial.

2

The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics.

Solèr M, Matz J, Townley R, Buhl R, O'Brien J, Fox H, Thirlwell J, Gupta N, Della Cioppa G. Solèr M, et al. Eur Respir J. 2001 Aug;18(2):254-61. doi: 10.1183/09031936.01.00092101. Eur Respir J. 2001. PMID: 11529281 Free article. Clinical Trial.

3

The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma.

Buhl R, Hanf G, Solèr M, Bensch G, Wolfe J, Everhard F, Champain K, Fox H, Thirlwell J. Buhl R, et al. Among authors: soler m. Eur Respir J. 2002 Nov;20(5):1088-94. doi: 10.1183/09031936.02.00016502. Eur Respir J. 2002. PMID: 12449159 Free article. Clinical Trial.

4

Omalizumab, a monoclonal antibody against IgE for the treatment of allergic diseases.

Solèr M. Solèr M. Int J Clin Pract. 2001 Sep;55(7):480-3. Int J Clin Pract. 2001. PMID: 11594260

5

Omalizumab for severe allergic asthma: 7 years and open questions.

Solèr M. Solèr M. Respiration. 2014;88(2):158-61. doi: 10.1159/000360771. Epub 2014 May 9. Respiration. 2014. PMID: 24818580 Review.

6

Insufficient control of asthma: increase the dose of inhaled steroids or add long-acting beta 2-agonists?

Aubert JD, Quadri F, Solèr M. Aubert JD, et al. Among authors: soler m. Schweiz Med Wochenschr. 1997 Feb 1;127(5):176-81. Schweiz Med Wochenschr. 1997. PMID: 9042686 Review.

7

[Benralizumab: Targeting the IL-5 Receptor in Severe Eosinophilic Asthma].

Leuppi JD, Schmid-Grendelmeier P, Rothe T, von Garnier C, Simon HU, Schuoler C, Pendl G, Solèr M. Leuppi JD, et al. Among authors: soler m. Praxis (Bern 1994). 2019;108(7):469-476. doi: 10.1024/1661-8157/a003222. Praxis (Bern 1994). 2019. PMID: 31136272 Free article. German.

8

[Benralizumab: Targeting the IL-5 Receptor in Severe Eosinophilic Asthma].

Leuppi JD, Schmid-Grendelmeier P, Rothe T, von Garnier C, Simon HU, Schuoler C, Pendl G, Solèr M. Leuppi JD, et al. Among authors: soler m. Praxis (Bern 1994). 2019;108(7):1-8. doi: 10.1024/1661-8157/a003250. Praxis (Bern 1994). 2019. PMID: 31136278 German.

9

Bronchoprotection by salmeterol: cell stabilization or functional antagonism? Comparative effects on histamine- and AMP-induced bronchoconstriction.

Solèr M, Joos L, Bolliger CT, Elsasser S, Perruchoud AP. Solèr M, et al. Eur Respir J. 1994 Nov;7(11):1973-7. Eur Respir J. 1994. PMID: 7875267 Free article. Clinical Trial.

10

[Monoclonal antibodies for severe asthma (review)].

Solèr M. Solèr M. Ther Umsch. 2019 Nov;76(6):317-321. doi: 10.1024/0040-5930/a001102. Ther Umsch. 2019. PMID: 31762416 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,149 results

Search Page

Filters